Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
TransCode Therapeutics (RNAZ) Q2 2025 Earnings
RNAZ
14
May
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-56
-37.53
-19.05
-0.58
Details
Expected EPS
-56
Actual EPS
N/A
Surprise EPS
56
Surprise Percent
+100%
Description
TransCode Therapeutics (RNAZ) will report earnings of for Q2 2025 on May 14, 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login